Proto Labs (PRLB) EBT (2011 - 2026)

Proto Labs has disclosed EBT across 16 years of filings, most recently posting $11.3 million for Q1 2026.

• EBT for Q1 2026 came in at $11.3 million, up 89.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $36.4 million (up 58.71% YoY), and the FY2025 annual result was $31.1 million, up 25.9% from the prior year.
• EBT came in at $11.3 million for Q1 2026 at Proto Labs, up from $8.2 million in the prior quarter.
• In the past five years, EBT ranged from a high of $11.3 million in Q1 2026 to a low of -$116.7 million in Q4 2022.
• The 5-year median for EBT is $7.4 million (2024), against an average of -$169058.8.
• Across the five-year window, EBT tumbled 1002.44% in 2022 and jumped 2990.78% in 2025, its largest moves.
• Proto Labs' EBT stood at -$116.7 million in 2022, then soared by 108.52% to $9.9 million in 2023, then plunged by 102.84% to -$282000.0 in 2024, then surged by 2990.78% to $8.2 million in 2025, then surged by 38.82% to $11.3 million in 2026.
• The last three EBT figures came in at $11.3 million (Q1 2026), $8.2 million (Q4 2025), and $10.3 million (Q3 2025), per Business Quant data.